adenocarcinoma of prostate

基本解釋

Prostate specific antigen density DPSA was studied in 11 cases of incidental adenocarcinoma of prostate and 20 cases of benign prostatic hyperplasia (BPH).
爲(wèi)探討前列腺偶發(fā)癌早期診斷的有傚指標(biāo)，對11例前列腺偶發(fā)癌和20例前列腺增生癥（BPH）患者前列腺特異性抗原密度（DPSA）進(jìn)行了檢測。
Using RNA interference and anti-sense RNA techniques to knock down the CD44 expression in PC-3 cells, and investigate the reverse of prostate adenocarcinoma's malignant phenotype;
通過RNA乾涉和反義RNA技術(shù)消除CD44基因在前列腺癌PC一3細(xì)胞中的表達(dá)，進(jìn)而考察下調(diào)CD44表達(dá)對腫瘤惡性表型的逆轉(zhuǎn)。
Methods The clinical and pathological data from 3 cases of basal cell adenocarcinoma and 1 case of basal cell adenoma of prostate were reviewed. All the cases were followed up.
方法：對基底細(xì)胞腺癌3例，基底細(xì)胞腺瘤1例，複習(xí)其臨牀和病理資料及進(jìn)行隨訪。